Lindbrook Capital, LLC Abb Vie Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 11,499 shares of ABBV stock, worth $2.07 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

11,499

Previous 11,234 2.36%

Holding current value

$2.07 Million

Previous $1.93 Million 17.86%

% of portfolio

0.19%

Previous 0.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$163.84 - $199.33 $43,417 - $52,822	265 Added 2.36%	11,499 $2.27 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $116,247 - $135,750	751 Added 7.16%	11,234 $1.93 Million
Q1 2024 Apr 25, 2024	BUY	$159.82 - $182.1 $110,115 - $125,466	689 Added 7.03%	10,483 $1.91 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $81,321 - $91,587	591 Added 6.42%	9,794 $1.52 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $84,028 - $97,274	629 Added 7.34%	9,203 $1.37 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $236,000 - $293,686	-1,781 Reduced 17.2%	8,574 $1.16 Million
Q1 2023 Apr 26, 2023	SELL	$144.61 - $166.54 $36,586 - $42,134	-253 Reduced 2.38%	10,355 $1.65 Million
Q4 2022 Jan 24, 2023	BUY	$138.31 - $165.87 $130,564 - $156,581	944 Added 9.77%	10,608 $0
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $166,286 - $190,719	1,239 Added 14.71%	9,664 $1.3 Million
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $22,432 - $28,518	163 Added 1.97%	8,425 $1.29 Million
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $38,934 - $48,306	-295 Reduced 3.45%	8,262 $1.34 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $437,992 - $554,186	4,077 Added 91.0%	8,557 $1.16 Million
Q2 2021 Jul 27, 2021	SELL	$105.21 - $117.21 $95,109 - $105,957	-904 Reduced 16.79%	4,480 $505,000
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $11,662 - $12,838	114 Added 2.16%	5,384 $583,000
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $52,559 - $70,961	653 Added 14.14%	5,270 $565,000
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $3,350 - $3,932	-39 Reduced 0.84%	4,617 $404,000
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $31,475 - $42,119	429 Added 10.15%	4,656 $457,000
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $43,408 - $65,812	-673 Reduced 13.73%	4,227 $322,000
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $11,035 - $13,808	153 Added 3.22%	4,900 $434,000
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $13,477 - $16,204	214 Added 4.72%	4,747 $359,000
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $20,498 - $26,201	-312 Reduced 6.44%	4,533 $329,000
Q1 2019 Apr 23, 2019	BUY	$77.14 - $90.79 $74,440 - $87,612	965 Added 24.87%	4,845 $390,000
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $302,058 - $372,518	3,880 New	3,880 $357,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Abb Vie Inc. Transaction History